Clinical Investigators' Day, October 5, 2018 by Cornell University. College of Veterinary Medicine & Clinical Investigators' Day Organizing Committee
Clinical Investigators’ 
Day 
October 5, 2018 
Lecture Hall III 
i 
Welcome to the 2018 Clinical Investigators’ Day, sponsored by the Cornell University College of Veterinary 
Medicine. The primary goal of this forum is to provide an opportunity for residents and interns to showcase 
ongoing investigations carried out at Cornell University College of Veterinary Medicine. It is our hope that 
greater insights will be gained in the breadth and depth of clinical investigations conducted at the College 
and will serve as a catalyst to promote greater interactions among colleagues with clinical and basic science 
research interests.   
Organizing Committee 
Ms. Gail Babcock 
Dr. Elizabeth Buckles, Co-Chair 
Dr. Jonathan Cheetham 
Dr. Erin Daugherity, Co-Chair 
Mr. Kim Eaton 
Mr. Doug Fink 
Ms. Beline Falzon 
Mr. Justin Limper 
Dr. Mary Martin, Co-Chair 
Ms. Suzette Moschetti 
Dr. Santiago Peralta 
Dr. Tracy Stokol, Co-Chair 
The organizing committee thanks the following individuals who contributed to the success of the Day: 
Mr. Dave Frank 
Mr. Drew Kirby 
Mr. Chad Westmiller 
Disclaimer: The information presented in this publication comes exclusively from the contributing authors and their mentors identified in each abstract. These 
abstracts are preliminary and should not be cited in bibliographies. Material contained herein may be treated as personal communication and should be cited as 
such only with the consent of the author. 
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Sponsors 
We thank the following sponsors for their generous support and commitment to Clinical Investigators’ Day: 
Corporate Sponsors 
College of Veterinary Medicine 
Animal Health Diagnostic Center 
Baker Institute for Animal Health 
Continuing Education and Events 
Cornell University Hospital for Animals 
Department of Biomedical Sciences 
Department of Clinical Sciences 
Department of Molecular Medicine 
Department of Population Medicine and Diagnostic Sciences 
Feline Health Center 
Office of the Dean 
Office of Research and Graduate Education 
University Programs 
Center for Animal Resources and Education (CARE) at Cornell University 
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Current CVM Clinical Trials 
Dogs 
 Lymphoma tissue banking
 Metabolomics investigation of Canine GI
disease
 Improving the diagnosis of degenerative
myelopathy with imaging
 Biomarker guided antimicrobial therapy for
septic peritonitis
 Flow cytometric analysis of platelets from
thrombocytopenic dogs
 Evaluation of StablePlate Rx™ in
Thrombocytopenic Patients
 Effects of spironolactone on arrhythmia
burden and heart rate variability parameters in
dogs with clinical dilated cardiomyopathy
 Targeted therapies for treating Canine
Lymphoma
 Determine the transcriptome of canine soft
tissue sarcoma
 Indirect computed tomographic lymphography
for sentinel lymph node mapping
 Drug repurposing to aid tx of canine
lymphoma
 Uncovering mechanisms of post-procedural
hypocalcemia in dogs with hyperthyroidism
 Assessment of dietary intervention in Canine
Inflammatory Bowel Disease and Canine
Kidney Disease
 Evaluation of the effect of antibiotic use on the
fecal flora: Dynamics of antibiotic resistance
over time
 Evaluation of recombinant, attenuated Listeria
monocytogenes expressing a chimeric human
HER2/neu protein in dogs with osteosarcoma
– COTC026
 Radiofrequency therapy for dogs with chronic
osteoarthritis hind limb pain
More trials coming!
Cats 
 Carboplatin in injection site sarcomas
 Characterization of subgingival micro-
environment
 Senior feline common disorders
 Feline sepsis response
 Effect of phenobarbital on thyroid tests
Rabbits 
 Diagnosing gastric outflow obstruction
 Characterization of normal ear canal cytology
and microbiology (in ferrets too!)
Horses 
 Relationships between body mass index (BMI)
and surgical site infection (SSI ) in horses
 Improving recovery from anesthesia for horses:
Draining the bladder
Sloths 
 Assessment of vitamin D metabolism and
calcium homeostasis in indoor-housed
Hoffmann’s two-toed sloths
For more information or to participate contact: 
vet-research@cornell.edu  
or call 
607.253.3279
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Program Schedule
Friday, October 5, 2018 
Lecture Hall 3, Veterinary Research Tower 
8:25 am – 8:30 am 
8:30 am – 9:00 am 
9:00 am – 10:30 am 
Welcome & Introductions – Robert Weiss, PhD; Associate Dean for Research and 
Graduate Education. The Clinical Investigator’s Day Organizing Committee 
Guest Presentation 
Being a Mom Is Hard: Calcium Demands of Early Lactation Dairy Cows 
Jessica McArt, DVM, PhD; Assistant Professor. Cornell University, Department of 
Population Medicine and Diagnostic Sciences 
Resident Presentations – Moderated by Sabine Mann, VMD, PhD 
 Use of Novel DNA Damage Response Inhibitors to Overcome Chemoresistance in Feline Solid
Tumors
Yike Bing, DVM – Medical Oncology Resident    Pg. 1
Pg. 2
Pg. 3
Pg. 4
Pg. 5
• The Role of High-Density Lipoproteins (HDL) in Modulating Neutrophil 
Activation During the Transition Period in Cows
José Daniel Cruz Otero, DVM – Clinical Pathology Resident
• Anticancer Effects of Cannabidiol (CBD) – in Vitro Results of CBD on 
Proliferation and Death of Canine Neoplastic Cell Lines
Joshua Henry, DVM – Medical Oncology Resident
• Assessment of Vitamin D Metabolites and Serum Cytokines in Dogs with 
Immune Mediated Disease
Philippe Mick, DVM – Small Animal Internal Medicine Resident
• Evaluation of Arsenic, Cadmium, Lead and Mercury Contamination in
Over-The-Counter Available Dry Dog Foods with Different Ingredients
(Red Meat, Poultry and Fish)
Hunter Kim, DVM, MS – Clinical Nutrition Resident
• Biological Variation of Symmetric Dimethylarginine and Other Biochemical 
Analytes in Clinically Healthy Cats
Jennifer Prieto, DVM, MS – Small Animal Internal Medicine Resident Pg. 6
10:30 am – 10:45 am Break 
v 
Schedule (cont.)
10:45 am – 12:00 pm Resident Presentations – Moderated by Elizabeth Moore, DVM 
Pg. 7
Pg. 8
Pg. 9
Pg. 10
• Diagnosis of Septic Peritonitis Using Effusion-Blood Gradients of Novel 
Biomarkers in Dogs
Pia Martiny, DVM – Emergency and Critical Care Resident
• Clinical, Clinicopathologic, and Hepatic Histologic Features Associated
with Suspected Ketoconazole Hepatotoxicity in 9 Dogs
Luis Macho, DVM – Small Animal Medicine Resident
• Validating the Use of a Smartphone-Based Noninvasive Electrocardiogram in Mice 
Rachael N. Labitt, DVM – Laboratory Animal Medicine Resident
• Agreement of Equine Stall-Side and Laboratory Major Cross Match Test
in Healthy Horses
Melissa Fenn, DVM – Large Animal Internal Medicine Resident
• Bile Acids as Prognostic Indicator for Horses with Liver Disease:
A Retrospective Study
Barbara Delvescovo, DVM, MRCVS – Large Animal Medicine Resident Pg. 11
12:00 pm – 12:45 pm Lunch 
12:45 pm – 3:00 pm Resident Presentations – Moderated by April Choi, DVM, PhD, DAVCP 
 Ethanol Injected Intracoelomically as a Novel Method of Euthanasia in Zebra Finches
(Taeniopygia Guttata) and Chickens (Gallus Gallus Domesticus)
Nathaniel S. Kollias, DVM, MPH – Lab. Animal Medicine Resident Pg. 12
 Dens Invaginatus in Dogs - a Case of Mistaken Identity?
Kevin Ng, BSc, BVMS (Hons) – Dentistry and Oral Surgery Resident Pg. 13
 Evaluation of On-Farm Microbiology Techniques for Detection of Pathogens in Milk
Renato Rossi, BVSc – Ambulatory and Production Medicine Resident Pg. 14
 Evaluation of Antimicrobial Administration in Critically Ill Dogs on the Fecal
Flora: Dynamics of Antimicrobial Resistance over Time
Sarah Robbins, MS, DVM – Emergency and Critical Care Resident Pg. 15
 Epidemiological Investigation of Orofacial Clefts in Purebred Dogs
Nicholas Roman – Dual DVM / MPH Student Pg. 16
vi 
 An Analysis of Medical Error Type and Severity in Veterinary Hospitals
Through the Use of an Incident Reporting System
Jessica Wallis, BVSc (Hons) – Emergency and Critical Care Resident Pg. 17
2:30 pm – 2:45 pm Break 
2:45 pm – 4:00 pm Resident Presentations – Moderated by Bryant Blank, DVM, MS, DACLAM 
Pg. 19
Pg. 20
Pg. 21
• QT Restitution in Boxers with ARVC: Relationship to Arrhythmia 
Vulnerability and Treatment Response
Christophe Bourguignon, DVM – Cardiology Resident
• Assessing the Effects of Cisapride and Buprenorphine on Gastrointestinal 
Transit Time in Rabbits
Erica Feldman, DVM – Laboratory Animal Medicine Resident
• Proximal Sesamoid Bone Microdamage and Fracture Toughness in 
Thoroughbred Racehorses
Lauren Luedke, DVM – Large Animal Surgery Resident
• Indirect Computed Tomographic Lymphography (Ictl) for Sentinel Lymph Node 
Mapping in a Cohort of Dogs with Cutaneous Mast Cell Tumor – Technique 
Development and Effect on Peri-Operative Decision Making and Post-Operative 
Treatment / Monitoring Recommendations
Janis Lapsley, DVM – Small Animal Surgery Resident
• SOX2 Expression in Canine Malignancies
Ileana Miranda, DVM, MS – Anatomic Pathology Resident Pg. 22
4:05 pm – 4:45 pm Keynote Address 
Equine Mesenchymal Stem Cells in Veterinary Medicine: Prospects and Challenges 
Gerlinde Van de Walle, DVCM, PhD; Professor in Equine Health, Department of 
Microbiology and Immunology 
5:00 pm Award Presentations 
Lorin Warnick, DVM, PhD; Dean, College of Veterinary Medicine 
Following Awards Reception (All Welcome!) 
Pg. 18
 vii 
 
Keynote Speaker 
 
 
Gerlinde Van DeWalle, DVM, PhD; Harry M. Zweig Assistant Professor in Equine 
Health, Cornell University 
 
Dr. Gerlinde Van de Walle earned her DVM and PhD from Ghent University in Belgium, 
where she stayed on as a Postdoctoral Research Fellow and then as an Assistant Professor in 
the Department of Comparative Physiology and Biometrics. She is currently Assistant 
Professor at the Baker Institute for Animal Health at Cornell University where her research 
focuses on new avenues of therapeutic intervention by better understanding the pathogenesis 
of diseases important to veterinary and human medicine. 
 
 
Guest Speaker 
 
Dr. Jessica McArt, DVM, PhD; Section Chief, Ambulatory and Production Medicine 
Clinic, Cornell University Hospital for Animals 
 
Dr. Jessica McArt is an Assistant Professor in the Department of Population Medicine and 
Diagnostic Sciences at Cornell University. She is Section Chief for the Ambulatory and 
Production Medicine Clinic, teaches veterinary students both in the classroom and on farms, 
and conducts applied research on periparturient diseases in dairy cattle. 
 
 
 
  
Moderators 
 
Bryant Blank, DVM, MS, DACLAM; Assistant Director, Agriculture Animals, 
Center for Animal Resources and Education (CARE) at Cornell University 
 
Dr. Blank is a clinical veterinarian at the Center for Animal Resources and Education (CARE). 
He received his DVM from Kansas State University in 2009. He then completed a three-year 
veterinary residency in laboratory animal medicine at Cornell University. During this period he 
received his MS in Comparative Biomedical Sciences working on the pathogenesis of Listeria 
monocytogenes. Bryant is a Diplomate of the American College of Laboratory Animal 
Medicine. 
 
He currently provides clinical care for a variety of species, oversees multiple rodent vivaria, maintains regulatory 
oversight of large agricultural facilities, and assists in CARE’s residency training program and veterinary student 
rotations. He is involved in multiple research collaborations involving a diversity of species and fields, including 
reproductive physiology of the Giant Pouched Rat, safety assessment of a synthetic joint lubricant, patient derived 
tumor xenotransplantation novel treatment studies and welfare parameters associated with trio-breeding of mice. 
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Moderators (cont.) 
 
April Choi, DVM, PhD, DAVCP; Clinical Instructor, Cornell University Department of 
Biomedical Sciences 
 
Dr. April Choi is a clinical instructor in the Department of Biomedical Sciences, Section of 
Anatomic Pathology at Cornell University College of Veterinary Medicine. She earned her 
DVM degree from South Korea and her PhD from the University of Queensland, Brisbane, 
Australia where she worked on diagnostic glycoprotein biomarkers for canine 
hemangiosarcoma. 
Prior to her current position, she completed her residency training at Cornell University and 
she is board certified by the American College of Veterinary Pathologists (ACVP). Dr. Choi’s research interests focus 
on diagnostic pathology with special emphasis on tumor immunodiagnostics and small animal hepatobiliary disease. 
 
 
Sabine Mann, VMD, PhD, Assistant Professor of Ambulatory and Production Medicine 
Clinic, Cornell University Department of Population Medicine and Diagnostic 
Sciences 
 
Dr. Sabine Mann is an Assistant Professor in the Ambulatory and Production Medicine Clinic, 
Department of Population Medicine and Diagnostic Sciences. She graduated with her 
veterinary degree from Hannover University of Veterinary Medicine in 2007 and is board 
certified in the European College of Bovine Health Management, the American College of 
Veterinary Preventive Medicine, and is member of the Epidemiology Specialty. She received 
her German doctoral degree from the Ludwig-Maximilian-University in Munich in 2011. From 
2007-2012 Dr. Mann completed an internship and residency both in Ambulatory and in a referral clinic, and worked 
as a lecturer. 
 
She received her PhD through the BBS Comparative Biomedical Sciences program here at Cornell in 2016. Dr. Mann 
has a clinical appointment in the Ambulatory Clinic where she performs large animal farm visits with students. In 
addition, Dr. Mann´s research interests in large animals focus on the interplay of metabolism, nutrition, and the 
immune system in times of stress. 
 
Elizabeth Moore, DVM; Assistant Professor and the Anne Groot Sesquicentennial 
Fellow, Department of Biomedical Sciences, Section of Anatomic Pathology, Cornell 
University College of Veterinary Medicine 
 
Dr. Moore graduated with her DVM from Cornell in 2012, and completed the laboratory 
animal medicine residency with the Center for Animal Resources and Education (CARE) in 
2015. She began her PhD training in the field of Comparative Biomedical Sciences in the 
laboratory of Dr. Robert Weiss during her residency, and will be completing her graduate 
degree at the end of this year. 
 
Her Ph.D. work focuses on understanding the mechanisms that maintain genomic integrity. Her projects investigate 
the role of the Rad9-Hus1-Rad1 DNA repair clamp in double stranded DNA break repair, probe the mechanisms 
behind the unique chemosensitivity of testicular germ cell tumors, and explore the role of the Fanconi Anemia DNA 
repair pathway in cellular and hepatic metabolism. 
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Judges 
 
 
Dorothy P. Debbie, PhD; Senior Lecturer, Cornell University Department of 
Microbiology and Immunology 
 
Dr. Debbie is a senior lecturer in the Department of Microbiology and Immunology at the 
Cornell University College of Veterinary Medicine where she teaches bacterial pathogenesis to 
undergraduate, graduate, and veterinary students. 
 
She received her PhD at Stanford University studying bacterial genetics, then trained in 
bacterial pathogenesis with Stanley Falkow at the Stanford University School of Medicine. 
Prior to coming to Cornell, she was an Assistant Professor at the University of Colorado 
Health Sciences Center studying pathogenic mechanisms of Yersinia enterocolitica.  
 
 
 
Laura Goodman, PhD; Assistant Research Professor, Cornell University Department of 
Population Medicine and Diagnpstic Sciences 
 
Dr. Goodman is an emerging infectious disease researcher at the Cornell College of Veterinary 
Medicine who trained at the University of Michigan, Cornell, and Harvard. Her laboratory 
works on pathogen discovery, surveillance, and bridging the gap between research and 
diagnostics. 
 
Her work has investigated mechanisms of pathogen emergence and development of novel 
high-throughput testing methods. She leads the development efforts in the Molecular 
Diagnostics section of the Cornell Animal Health Diagnostic Center /NY State Veterinary Diagnostic Lab and 
currently serves on the New York State task forces for tick-borne diseases and antimicrobial resistance, which are 
focus areas in her laboratory. 
 
 
 
Scott Palmer, DVM; Adjunct Professor, Cornell University Department of Population 
Medicine and Diagnpstic Sciences 
 
Dr. Palmer received his veterinary degree from the University of Pennsylvania School of 
Veterinary Medicine in 1976 and is certified in equine practice by the American Board of 
Veterinary Practitioners. He worked in clinical practice as a staff surgeon and hospital director 
of the New Jersey Equine Clinic for 38 years prior to chairing the New York Task Force on 
Racehorse Health and Safety to investigate equine fatalities that occurred during Aqueduct’s 
2011-12 Winter Meet. 
 
Dr. Palmer currently serves as the Equine Medical Director for the New York State Gaming Commission and is an 
adjunct professor in the department of Population Medicine and Diagnostic Sciences at Cornell University College of 
Veterinary Medicine. His research focus is the identification of horses at increased risk for fatal musculoskeletal injury 
and development of intervention strategies to prevent fatal musculoskeletal injuries. 
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Judges (cont.) 
 
Heidi Reesink, VMD, PhD, DACVS-LA; Assistant Professor, Cornell University Large 
Animal Surgery 
 
Dr. Heidi Reesink is a board-certified large animal surgeon with clinical interests in orthopedic 
surgery and sports medicine. She received her veterinary degree from the University of 
Pennsylvania, followed by residency and PhD training at Cornell University.   
 
Dr. Reesink’s laboratory aims to unravel basic mechanisms underlying the development of 
orthopedic disease and to pioneer innovative therapies for the treatment of arthritis in equine, 
canine and human athletes. A major focus of the laboratory is understanding how glycans and 
glycoproteins, such as lubricin and hyaluronic acid, enable effective joint lubrication, mitigate inflammation and 
maintain cartilage homeostasis. The lab employs molecular biology, biochemistry, glycobiology and engineering 
techniques to investigate the role of glycans in osteoarthritis. A second major focus is deciphering how bone 
morphology and bone quality relate to catastrophic fracture in racehorses. Ongoing efforts include identifying 
quantitative CT parameters that can be used to estimate fracture risk. The lab uses epidemiology, advanced imaging, 
and fracture testing techniques to investigate these questions about racehorse fractures. 
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 Yike Bing, DVM 
yb74@cornell.edu  
Institution and Location 
Cornell University, Ithaca, New York 
University of Wisconsin, Madison, Wisconsin 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Medical Oncology, 2nd Year 
Degree 
DVM 
Internship 
Residency 
Year 
2016 
2017 
2017-Present 
 
Abstract Title: 
Use of Novel DNA Damage Response Inhibitors to Overcome Chemoresistance in Feline Solid Tumors 
 
Authors Names: 
Yike Bing, Abdo Dergham, Kelly R. Hume; Departments of Clinical Sciences, Cornell University, NY, 14853.  
 
Project Mentor: 
Kelly R. Hume, DVM, DACVIM, DVM; Department of Clinical Sciences 
 
Abstract: 
Introduction  
Chemoresistance is an obstacle in the treatment of feline solid tumors. We have previously found that DNA damage exists in 
varying degrees in untreated feline injection site sarcomas (FISS), and high levels of DNA damage reflected by high baseline 
expression of γH2AX was associated with resistance to carboplatin in vitro. Inhibiting cellular DNA repair mechanisms may 
help overcome chemoresistance. 
 
Objective 
To evaluate whether DNA damage response (DDR) inhibitors can enhance cytotoxicity of chemotherapeutics in feline solid 
tumor cells in vitro. 
 
Methods  
Using MTT (3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide) cell viability assay, 2 FISS cell lines and 1 feline oral 
squamous cell carcinoma (SCC) cell line were treated with serial dilutions of the following drugs: doxorubicin, carboplatin, 
NU7026 (DNA-PKcs inhibitor) and MK1775 (WEE1 inhibitor). These results were used to determine the drug concentration 
needed to decrease cell viability by 50% (IC50). These same cells were then treated with a combination of chemotherapeutic 
and low dose DDR inhibitor (NU7026, 2 and 5uM; MK1775, 0.5 and 0.75uM) to determine their chemosensitizing effect. 
Significance was analyzed using Student’s t-test to compare individual treatment to combination therapy. Degree of synergy 
was determined by calculating a combination index (CI) from IC50 values.    
 
Results/Discussion 
A synergistic effect was observed when SCC cells were treated with combination therapy with MK1775 (CI=0.47 for 
carboplatin, CI=0.79 for doxorubicin). This effect was not observed in combination therapy with NU7026, nor in FISS cells. 
MK1775 as a potential therapeutic agent for feline squamous cell carcinoma may be explored in future in vivo studies. 
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 José Daniel Cruz Otero, DVM 
jc3263@cornell.edu  
Institution and Location 
Tuskegee University, Tuskegee, Alabama 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Clinical Pathology, 3rd Year 
Degree 
DVM 
Residency 
Year 
2014 
2016-Present 
 
Abstract Title: 
The Role of High-Density Lipoproteins (HDL) in Modulating Neutrophil Activation During the Transition Period in Cows 
 
Authors Names: 
José Daniel Cruz Otero, Cheryl Wong, Erica Behling-Kelly; Department of Population Medicine and Diagnostic Sciences, 
Cornell University, Ithaca, New York  
 
Project Mentor(s): 
Erica Behling-Kelly, DVM, PhD, Dipl. ACVP; Department of Population Medicine and Diagnostic Sciences 
 
Abstract: 
Background 
The 3 weeks before and after calving, the transition period (TrPe), is a high-risk period for the development of costly 
production-related diseases in dairy cows. During the TrPe, changes in lipid metabolism are thought to contribute to disease 
risk. High-density lipoprotein (HDL) has anti-inflammatory activity in a number of species. We hypothesized that bovine HDL 
has immunomodulatory activity that is negatively impacted by the metabolic demands of the TrPe. 
 
Objective 
Test the biological impact of bovine HDL isolated throughout TrPe on neutrophil activation. 
 
Methods  
HDL was isolated from EDTA-anticoagulated blood collected weekly throughout the TrPe from 12 adult multiparous 
Holsteins using density gradient ultracentrifugation. Heparinized blood from mid-lactation cows was treated for 4 hours with 
50ng/ml LPS alone and in combination with 300mg/ml of isolated HDL. Dialysis buffer was the vehicle control. Neutrophil 
activation was determined by measuring changes in CD11b expression using flow cytometry.    
 
Results  
HDL decreased LPS-induced CD11b expression by 23% (SD ± 14.6) before calving. HDL from near-calving was less 
efficacious against neutrophil activation allowing over activation of neutrophils by 45% (SD ± 233.9). HDL did not regain 
immunomodulatory activity post-calving in 6/12 cows. 
 
Conclusion  
Bovine HDL decreases LPS-induced neutrophil activation in a manner that is dependent on the time relative to calving. The 
loss of HDL function near calving may contribute to the dysregulated inflammation that occurs during the TrPe in-vivo. Future 
studies are required to determine the HDL motif(s) involved in blunting LPS activity and identify interventions to help retain 
HDL’s effective immunomodulatory activity through the TrPe. 
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 Joshua G. Henry, DVM 
jgh95@cornell.edu  
Institution and Location 
Ross University, St. Kitts and Nevis 
University of Pennsylvania, Philadelphia, Pennsylvania 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Medical Oncology, 3rd Year 
Degree 
DVM 
Internship 
Residency 
Year 
2013 
2013-2014 
2016-Present 
 
Abstract Title: 
Anticancer Effects of Cannabidiol (CBD) – in vitro Results of CBD on Proliferation and Death of Canine Neoplastic Cell Lines 
 
Authors Names: 
Joshua G. Henry, Joseph J. Wakshlag, Cheryl E. Balkman 
Department of Clinical Sciences, Cornell University, Ithaca, New York 
 
Project Mentor(s): 
Joseph J. Wakshlag DVM, PhD, DACVN, DACVSMR, Department of Clinical Sciences (Co-mentor) 
Cheryl E. Balkman, DVM, DACVIM (SAIM /Oncology), Department of Clinical Sciences (Co-mentor) 
 
Abstract: 
Introduction 
Cannabidiol (CBD) has gained popularity both in the medical and mainstream communities for its medicinal properties while 
lacking the psychotropic aspect of other phytocannabinoids. Nutraceutical use by clients for their companion animals is 
common. However, evidence-based resources for informed client education are lacking. Phytocannabinoid studies in 
companion animal species are limited and no studies to date have evaluated the effects of CBD on canine neoplastic cell lines. 
 
Objective 
The objective of this study was to investigate the impact of CBD on the viability of 5 canine neoplastic cell lines (HMPOS, 
D17, Abrams, CMT-12, 17-71) treated with CBD alone and in combination with doxorubicin at various concentrations. 
 
Methods  
Cells were plated in 96-well tissue culture plates and incubated for 48 hours with vehicle control (ethanol), CBD, doxorubicin, 
or CBD and doxorubicin at varying concentrations. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assays were performed and optical density was analyzed by a spectrophotometric plate reader. Results between the different 
groups were compared to determine the anti-proliferative effect of CBD alone and in combination with doxorubicin.    
 
Results  
All cell lines exhibited anti-proliferative sensitivity to CBD at physiologically attainable concentrations. The combination of 
CBD and doxorubicin had variable combinatorial effects on cell viability and appears concentration dependent. 
 
Conclusion  
Further research of cannabidiol as an adjuvant therapy for canine neoplasms is warranted in the pre-clinical and clinical setting. 
Additional research is necessary to elucidate its combinatory effects with standard chemotherapies and to understand its 
mechanism of action. 
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 Phillip J. Mick, DVM 
pjm352@cornell.edu  
Institution and Location 
Washing State University, Pullman, Washington 
Cornell University, Ithaca, New York 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Small Animal Internal Medicine, 1st Year 
Degree 
DVM 
Internship 
Residency 
Year 
2017 
2018 
2018-Present 
 
Abstract Title: 
Assessment of Vitamin D Metabolites and Serum Cytokines in Dogs with Immune Mediated Disease 
 
Authors Names: 
Phillip J. Mick, John P. Loftus, Joseph J. Wakshlag; Cornell University, College of Veterinary Medicine, Ithaca, New York 
 
Project Mentor(s): 
John P. Loftus, DVM, PhD, DACVIM; Department of Clinical Sciences 
 
Abstract: 
Introduction 
Reduced vitamin D levels may be associated with immune mediated disease (IMD) and a poorer prognosis. Vitamin D 
isoforms, particularly calcitriol, have immune modulatory effects and may alter immune pathways associated with 
autoimmunity.  
 
Methods 
Serum was collected from canine patients diagnosed with immune mediated disease (immune mediated hemolytic anemia, 
thrombocytopenia, polyarthritis, steroid responsive meningitis arteritis). Vitamin D metabolites were measured by LC-MS/MS 
at an accredited lab.  IL-17 and IL-10 were measured with commercially available canine-specific enzyme-linked 
immunosorbent assay (ELISA) kits.  
 
Results 
Serum 25(OH)D3 and 1,25(OH)2D3 were significantly reduced in dogs with IMD compared to healthy controls.  Serum IL-10 
levels were not significant between controls and dogs IMD.  All dogs had IL-17 levels below the standard curve.  However, 
estimated IL-17 levels were significantly increased in dogs with IMD (P = 0.02), though all were below the standard curve.  
The median survival time (MST) for dogs with 25(OH)D3 concentrations </= the median was 106 days, while dogs with 
concentrations of 25(OH)D3 > the median did not achieve a MST at the conclusion of the study (77.14% survival at 871 
days).  
 
Conclusion 
Decreased serum 25(OH)D3 and 1,25(OH)D3, but not 24,25(OH)D3 are associated with canine IMD.  IL-17 levels appear to 
be higher in dogs with IMD, but more sensitive reagents for detection of canine serum IL-17 are needed.  Vitamin D 
metabolites represent a prognostic marker as well as a future area for targeted therapy in canine IMD. Additional research is 
needed before vitamin D analogs or metabolites should be considered for therapeutic use.  
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 Hunter (Hyun-tae) Kim, DVM, MS 
hk894@cornell.edu  
Institution and Location 
Kangwon National University, ChunCheon, S. Korea 
Seoul National University, Seoul, S. Korea 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Clinical Nutrition, 3rd Year 
Degree 
DVM 
MS 
Residency 
Year 
2011 
2015 
2016-Present 
 
Abstract Title: 
Evaluation of Arsenic, Cadmium, Lead and Mercury Contamination in Over-The-Counter Available Dry Dog Foods with 
Different Ingredients (Red Meat, Poultry and Fish) 
 
Authors Names: 
Hyun-tae Kim, John P Loftus, Sabine Mann, Joseph J. Wakshlag; Cornell University, College of Veterinary Medicine, Ithaca, 
New York 
 
Project Mentor(s): 
Joseph J. Wakshlag, DVM, PhD, ACVN, ACVSMR; Department of Clinical Sciences 
 
Abstract: 
There are few reports of heavy metal contamination of commercial dog foods and an increasing awareness of this issue by 
consumers.  In an effort to understand toxic heavy metal content in commercial dog foods, arsenic, cadmium, lead and 
mercury of 51 over-the-counter maintenance or all-life-stage dry dog foods were examined by inductively coupled plasma 
mass spectrometry, that were classified as  poultry-, red meat- or fish-based. Variables examined in this dataset were 
differences based on major protein source in the diet (poultry vs. red meat vs. fish).  A non-Gaussian data distribution led to 
non-parametric statistical testing (Wilcoxon rank sum/Kruskal Wallis tests) and median (range) descriptive statistics.  
Comparison to average human consumption based on mg/Mcal was also examined.  On average, total heavy metal 
consumption is higher in dogs than in humans. However, chronic toxic exposure levels are highly unlikely based on canine 
toxicity studies.  Fish-based diets had significantly higher arsenic, cadmium and mercury content than the other poultry or 
red meat-based diets (p<0.004).  Red meat-based diets (beef, venison and bison) had higher lead concentration than poultry 
and fish-based diets (p<0.03). Based on these findings, commercial dog foods appear to be safe for chronic consumption 
and concentrations of the heavy metals were dependent on primary protein sources. Overall, poultry-based diets had 
relatively lower heavy metal content than red meat and fish-based diets. These findings may be useful for establishing safe 
upper limits of heavy metals in pet foods although it is necessary to further investigate the bioavailability of these elements 
in dogs. 
 
Learning Objective 
Measure and understand heavy metal concentrations in commercial dog foods 
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 Jennifer Prieto, DVM, MS 
jmb279@cornell.edu  
Institution and Location 
Cornell University, Ithaca, New York 
Cornell University, Ithaca, New York 
Veterinary Medical Center of CNY, Syracuse, New York 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Small Animal Internal Medicine, 3rd Year 
Degree 
DVM 
PhD 
Internship 
Residency 
Year 
2013 
2015 
2016 
2016-Present 
 
Abstract Title: 
Biological Variation of Symmetric Dimethylarginine and Other Biochemical Analytes in Clinically Healthy Cats 
 
Authors Names: 
J.M. Prieto1, P.C. Carney1, M.L. Miller1, M. Rishniw1, J.F. Randolph1, G. Farace2, G. Bilbrough2, M. Yerramilli2, 
M.E. Peterson1,3 
 
1Cornell University, College of Veterinary Medicine, Department of Clinical Sciences Ithaca, New York 
2IDEXX Laboratories Inc., Westbrook, Maine 
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Abstract: 
Background 
Symmetric dimethylarginine (SDMA) is a marker of kidney function increasing earlier than creatinine in cats with chronic 
kidney disease. Biological variation of biochemical analytes, including SDMA, determines whether population-based reference 
intervals are appropriate when interpreting whether a particular change is clinically relevant for a specific individual. 
 
Hypothesis/Objectives 
To evaluate the biological variation of SDMA and other serum biochemical analytes in ten clinically healthy cats.  
 
Methods 
Prospective, observational study in which cats were sampled for serum biochemical analyses once weekly for six weeks. 
Samples were frozen and then single-batch analyzed. Outliers were identified, and restricted maximum likelihood estimation 
used to determine the coefficients of variation (CV) describing variation within each cat and between cats. The CV determined 
the individuality indices and reference change values (RCV). 
 
Results 
Seven analytes (alkaline phosphatase, cholesterol, albumin, creatinine, blood urea nitrogen, phosphorus, total protein) had high 
individuality indices, best evaluated based by RCV. One analyte (aspartate aminotransferase) had a low index of individuality, 
best evaluated by a population-based reference interval. Seven analytes (SDMA, creatine kinase, potassium, glucose, total 
bilirubin, calcium, alanine aminotransferase) had intermediate indices of individuality, best evaluated by combination of RCV 
and population-based reference intervals. 
 
Conclusions 
Clinicians should consider biological variation when selecting the best method for interpreting changes in biochemical analytes. 
Specifically, establishing each cat’s baseline values and applying RCV to subsequent measurements of analytes with high indices 
of individuality may improve recognition of meaningful biological changes. In most situations, SDMA concentrations can be 
evaluated against population-based reference intervals. 
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Abstract: 
Septic peritonitis (SP), defined as the presence of bacteria within the abdominal cavity, is common in dogs and is associated with 
high mortality. Early recognition and aggressive management are essential to maximizing survival. Few biomarkers for diagnosis 
of SP have been evaluated in dogs to date. This study aimed to evaluate the utility of novel biomarkers for the diagnosis of SP in 
dogs. 
 
Objective 
To evaluate the hemodynamic effects of two doses of atipamezole administered intramuscularly (IM) to anesthetized cats 
receiving dexmedetomidine. 
 
Methods  
Eighteen dogs with SP and 19 age-matched controls with evidence of systemic inflammation but non-septic abdominal effusion 
(NSP) were prospectively enrolled. Blood and effusion were obtained at presentation, and concentrations of cfDNA, glucose, 
HMGB-1, inflammatory cytokines, lactate, NT-proCNP, NGAL, nucleosomes, and procalcitonin measured. Effusion-blood 
gradients were compared between dogs with SP and with NSP by Mann-Whitney U test. ROC curve analysis and calculation of 
AUROC was used to determine the gradients most discriminating for SP. Bonferroni corrections were used to adjust for multiple 
comparisons.    
 
Results 
Compared to NSP, dogs with SP had significantly greater effusion-blood gradients of CCL2, IL-6, IL-10, and lactate (all 
P≤0.0255), and significantly smaller effusion-blood gradients of glucose (P=0.0135). ROC curve analysis indicated that these 5 
biomarkers were discriminant for the differentiation of SP from NSP. The most discriminating was IL-10 (AUROC 0.8216, 
P=0.012). 
 
Conclusion  
This study suggests that effusion-blood gradients of IL-10, CCL2, glucose, lactate and IL-6 discriminate SP from NSP in dogs. 
Considering ease of measurement and good discriminating performance, this study supports the measurement of effusion-
blood gradients of glucose and lactate for identification of SP in dogs. 
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Abstract: 
Background 
Ketoconazole hepatotoxicity is anecdotally described in dogs. 
 
Animals 
9 client-owned dogs 
 
Methods 
Review of liver biopsies spanning 3 years identified a unique pattern of lipofuscin-engorged macrophages and liver 
injury coordinating with oral ketoconazole administration in 9 dogs. Signalment, clinical signs, clinicopathologic 
and abdominal ultrasound findings, hepatic histopathologic features, ketoconazole dosage and duration, concurrent 
treatments, antecedent illnesses, and survival of these 9 dogs were recorded. Hepatic histopathologic features were 
scored semi-quantitatively (Mild, moderate severe), by a pathologist and internist with special interest in hepatic 
pathology, and summated. Hepatic copper concentration was quantified with a colorimetric algorithm previously 
developed at Cornell. 
 
Results 
Dogs of 7 breeds, median age 8.4 (6-15) years, had received ketoconazole for atopy complicated by Malassezia; 
dose and duration ranged between 5-26 mg/kg/day administered for 3-156 weeks. Concurrent medications 
included macrocyclic lactones (6), antibiotics (3), antihistamines (3), glucocorticoids (2), cyclosporin (2), oclacitinib 
(2) and IL-31 monoclonal antibody (2). Clinical signs included lethargy (9), inappetence (9), and vomiting (7). All 
dogs had increased liver enzymes without jaundice with 3-fold increases in ALT (67%), AST (63%), ALP (33%), 
and GGT (33%). Histopathologic features included glycogen-type hepatocyte vacuolation (6), variable mixed portal 
and/or centrilobular inflammation, fibrosis or bridging (6), pyogranulomatous hepatitis (2), increased hepatocyte 
copper (5), and aggregates of lipofuscin-engorged macrophages (9). With ketoconazole discontinuation, 4 dogs 
remain alive (12-42 months) and 5 dogs were euthanized (6-12 months). Death was attributed to continued liver 
injury in 3 dogs (including 2 dogs with pyogranulomatous hepatitis). 
 
Conclusions and Clinical Importance 
Ketoconazole-associated hepatotoxicity has a necroinflammatory pattern and remnant lipofuscin-engorged 
macrophages reflecting oxidative damage. Awareness of potential drug-induced injury advises proactive monitoring 
of liver enzymes. 
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Abstract: 
Noninvasive electrocardiogram (ECG) devices are not often used in mice. They require restraint or anesthesia, expensive 
equipment, and are reported to produce ECGs of questionable quality. The gold standard for obtaining ECGs in mice is the 
invasive surgical implantation of telemetry devices. Telemeters allow for continuous ECG recording of unrestrained, 
unanesthetized mice. However, telemeter implantation requires invasive surgery and can be prohibitively expensive, and is 
therefore not practical to use as a screening tool. We validated the use of a smartphone-based, noninvasive, single lead ECG 
system in mice. The smartphone ECG transmits an ECG recording to a smartphone if placed in contact with the ventrum of a 
restrained, conscious mouse. The smartphone ECG is inexpensive, does not require surgery, and can be used to quickly screen 
animals for cardiac rhythm disturbances. We surgically implanted FVB mice and mice with known cardiac arrhythmias with 
telemeters and obtained simultaneous ECG recordings by telemetry and smartphone system. Recordings were obtained in 
restrained, conscious mice and in unrestrained, anesthetized mice. Results were evaluated blinded to genotype, but not 
recording method, due to differing formats. Rhythm was assessed by a veterinary cardiologist. The smartphone ECG produced 
good quality recordings in conscious mice and adequate quality recordings in anesthetized mice in ventral recumbency. Both 
methodologies produced ECGs of similar heart rate and rhythm, with lower resolution in the smartphone recordings. The use 
of a smartphone-based, noninvasive ECG in mice appears to be a cost effective, valuable screening tool for assessing mice for 
cardiac rhythm disturbances. 
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Abstract: 
Blood transfusions are often needed to treat anemic horses. Horses have 8 blood groups, with >30 factors, yielding >400,000 
potential blood types. Incompatible transfusions can cause life-threatening reactions. To avoid such reactions, crossmatches 
are usually performed in diagnostic laboratories but are technically difficult, labor-intensive, protracted and costly. An accurate 
point-of-care kit would overcome these limitations in emergencies or private practices. Our goal was to evaluate the 
performance of a rapid stall-side gel-based equine crossmatch kit (Alvedia; KIT) with the laboratory procedure (LAB) in 
horses of known and unknown blood types. Expected positive (n=34) and negative (n=35) crossmatches were established 
using 21 blood typed and antibody screened horses and known antisera. The sensitivity and specificity (95% confidence 
intervals) for expected reactions were 88 (73-97)% and 71 (54-85)% for KIT and 76 (59-89)% and 74 (57-88)% for LAB. 
Agreement was 65 and 63% for expected positive and negative reactions, respectively. The lowest agreement was found with 
anti-Aa (KIT positive, LAB negative in 8/12, 33% agreement), then anti-Qa (KIT negative, LAB positive in 4/10, 60% 
agreement) crossmatches, with 100% agreement for anti-Ca (KIT and LAB positive in 12/12) crossmatches. To mimic field 
situations when unscreened horses may be transfused with untyped blood, reciprocal crossmatches were performed in 69 
untyped/unscreened horses. Test results agreed in 89/138 (68%) (Cohen´s κ = 0.21 [0.04 to 0.38]) crossmatches. Our data 
showed that performance of both tests with expected positive reactions was blood type dependent. Agreement between the 
tests was fair for both expected and unknown reactions.   
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Abstract: 
Introduction 
Measurement of serum Bile Acids (BA) is used in horses to establish severity of liver disease and monitor response to 
treatment.  Recent published data from Europe supports the use of serum BA as a prognostic indicator of short and long-term 
outcome in horses. However, the etiopathology of hepatic disease in northeastern U.S. horses might differ from horses in the 
European study causing predictive outcome value of SBA to differ. Determining the prognostic value of SBA in Northeastern 
U.S. horses with liver dysfunction might therefore provide more accurate prognostic information on horses in this region. The 
prognostic value of serum gamma-glutamyltransferase (GGT) activity, the most commonly used biomarker for liver disease in 
horses was also evaluated in the study horses. 
 
Objective 
To retrospectively evaluate the predictive value of SBA and serum GGT activity on outcome in the population of horses 
presented to Cornell University, with both primary and secondary liver disease causing abnormally high serum BA. 
 
Results 
45 horses presented with liver disease and BA values above 30 μmol/L and were included in the study. 80% of the horses 
survived long term (>6 months). 
 
Logistic regressions for primary and secondary diseases showed no correlation between SBA values and long-term outcome 
(P=0.98) or GGT activity and outcome (P=0.52).  
 
Conclusions 
Serum BA concentration and GGT activity did not differ among survivors and non-survivors. According to these results, SBA 
do not seem to represent a good long-term prognostic indicator in this population of Northeastern U.S. horses with liver 
dysfunction. 
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Abstract: 
According to the AVMA Guidelines for Euthanasia of Animals 2013, injectable pentobarbital and inhalant CO2 are 
“acceptable” and “accepted with conditions” methods of euthanasia for avian species.  However, barbiturates are controlled 
substances and challenging to use in the field and laboratory setting. Additionally, there is limited literature on the use of CO2 
in avian species and flow rates are extrapolated from mammalian studies. Most importantly, CO2 has been reported to induce 
euthanasia inconsistently and is cited by users to be distressful. Recent studies have investigated intraperitoneal (IP) ethanol as 
an alternative to CO2 due to its unique pharmacological properties with results suggesting IP ethanol overdose is a humane 
euthanasia agent in mice, but is inconsistent in rats. Thus, we sought to determine if intracoelomic (IPc) 100% ethanol could 
be used as an alternative euthanasia agent in chickens. Chickens where fitted with ECG, capnography, doppler, and 
randomized into three groups: 20ml of 100% ethanol, 20ml saline, or 0.5ml of pentobarbital IPc.  Chickens receiving either 
pentobarbital or ethanol exhibited a smooth transition into anesthesia, with 5/7 birds in the ethanol group declared euthanized 
at approximately 10 minutes post injection and 5/7 pentobarbital birds declared euthanized at approximately 7 minutes.  Post 
mortem examination revealed no significant degradative tissue effects (histological examination and RNA extraction) with 
using ethanol as a euthanasia method. There were no significant aberrations appreciated on ECG recordings. We conclude that 
IPc ethanol overdose induces euthanasia inconsistently, which currently prevents it from being used as a euthanasia method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13 
 
 Kevin Ng, BSc, BVMS (Hons) 
kkn28@cornell.edu  
Institution and Location 
Murdoch University, Murdoch, Western Australia 
Cornell University, Ithaca, New York 
 
Current Position 
Intern. Companion Exotics, Wildlife and Zoo Medicine 
Degree 
BSc, BVMS 
Residency 
Year 
2006 
2016-Present 
 
Abstract Title: 
Dens Invaginatus in Dogs - a Case of Mistaken Identity? 
 
Authors Names: 
Kevin K. Ng1, Santiago Peralta1, Nadine Fiani1, April Choi2, Stacy Rine2 
 
1Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York  
2Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York  
 
Project Mentor(s): 
Santiago Peralta, DVM, Dipl. AVDC, Department of Clinical Sciences 
 
Abstract: 
Introduction  
Dens invaginatus is a rare developmental malformation of the tooth arising from the invagination of the enamel organ, 
resulting in additional layers of dental tissue. This malformation has been associated with early-onset periodontitis and pulp 
necrosis in dogs. The existing veterinary literature is limited to case reports and the internal structure of affected teeth has not 
been well described. The purpose of this study was to describe the radiographic and histological characteristics of teeth with 
suspected dens invaginatus using a variety of radiographic and histological methods. 
 
Materials Methods  
Four teeth from 3 dogs with suspected dens invaginatus were surgically extracted and stored in formalin. Full-mouth 
radiographs were performed for each dog. Radiographic analysis consisted of in vivo and ex vivo radiographs with an intraoral 
phosphor plate system, as well as high-resolution micro-computed tomography. Histologic examination of each tooth was 
performed with demineralized and non-demineralized methods, and immunohistochemistry.    
 
Results 
An area of abnormal mineralized tissue surrounded by disorganized dentin was identified within each tooth. In 3 teeth, the 
abnormal tissue extended to the external surface of the tooth, while in 1 tooth, the abnormal tissue was wholly contained 
within dentin. Small channels traversed the abnormal tissue, communicating with the pulp cavity and the external surface of 
the tooth. Invaginated enamel layers could not be confirmed in any of the affected teeth. 
 
Conclusions 
Radiographically, the findings reported here were dissimilar to previously described forms of dens invaginatus, but bore a close 
resemblance to a recently described developmental abnormality in humans known as molar-incisor malformation. 
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Abstract: 
On-farm culture systems are useful tools for pathogen based mastitis management in dairy cows which is advantageous for 
both economic reasons and to reduce antimicrobial use in livestock. We evaluated the use of 3 on-farm mastitis diagnostic 
assays: AccuMast® Mastitis Culture System (chromogenic media) and MN EasyTM Culture System Bi-plates and Tri-plates 
(selective media). A total of 628 milk samples submitted to Quality Milk Production Services for routine diagnostics in 2017 
were cultured simultaneously for 24h on test media and on blood agar for subsequent MALDI-TOF analysis (reference 
method). All on-farm culture plates were interpreted independently by trained and untrained readers based on the algorithm of 
the respective system. For the outcomes no growth, gram positive, gram negative, Staphylococcus aureus, Streptococcus 
species, Escherichia coli and Klebsiella we determined sensitivity, specificity, predictive values and strength of agreement 
between reader group and reference method. When interpreted by a trained reader all systems showed intermediate to high 
specificity (> 76%), negative predictive values (78.1 to 98.4%) and a moderate to good strength of agreement with the 
reference method for no growth, gram positive and gram negative. Untrained readers had lower test statistic values and only 
fair to moderate strength of agreement for these categories. Across all three systems and groups of pathogens trained readers 
showed moderate to good agreement with the reference method while none of the systems agreed well with the reference 
method when assessed by readers who only had access to the training materials provided by the three systems. 
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Abstract: 
Introduction  
Extensive antibiotic usage has exerted selection pressure leading to development of bacterial antimicrobial resistance (AMR) in 
organisms at the infection site, and within the commensal bacterial population. 
 
Objective 
To assess the effect of antibiotic administration to dogs with sepsis on the antimicrobial resistance patterns of the 
gastrointestinal microflora over a 60-day period. 
 
Methods  
Sixteen dogs with septic peritonitis (n=6), pyometra (n=5) and pneumonia (n=5) were prospectively enrolled. Fecal samples 
were collected for culture at-presentation and again seven and 60 days later. Escherichia coli isolates from each time point were 
tested for resistance against a panel of antibiotics including amoxicillin-clavulanate, ampicillin, cefazolin, cefovecin, 
cefpodoxime, cephalexin, chloramphenicol, clindamycin, doxycycline, enrofloxacin, imipenem, marbofloxacin, metronidazole, 
and orbifloxacin. Resistant isolate frequencies were compared between timepoints using binomial tests with post-hoc multiple 
comparisons correction using a 5% false discovery rate per Benjamini-Hochberg.    
 
Results 
Between admission and day seven, there were significant increases in the frequency of resistance in E. coli isolates against the 
following antibiotics (percent resistance at admission, percent resistance day 7, P-value): ampicillin (36.8%, 100%, P=0.008); 
cefazolin (15.8%, 100%, P=0.004); cefovecin (21.1%, 91%, P=0.008); cefpodoxime (15.8%, 90%, P=0.008); cephalexin 
(15.8%, 91%, P=0.008); enrofloxacin (15.8%, 92%, P=0.002); marbofloxacin (15.8%, 100%, P=0.002); orbifloxacin (15.8%, 
100%, P=0.002). There were no significant differences in resistance frequencies between admission and day 60. 
 
Conclusions 
In dogs with sepsis receiving antibiotics, fecal E. coli isolates developed antimicrobial resistance within seven days to multiple 
types of antimicrobials including drugs to which individuals were not exposed. This resistance diminished by day 60. 
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Abstract: 
Introduction 
Congenital orofacial clefts occur when the tissue that forms the primary or secondary palate fails to fuse during embryonic 
development, resulting in an abnormal fissure in the upper lip or roof of the mouth. Etiopathogenesis is multifactorial, 
involving genetic and environmental factors. These malformations have been reported in dogs and other species, including 
humans. Anecdotally, brachycephalic breeds seem overrepresented. Improved understanding of the frequency with which 
clefts occur as well as possible causes, predictors, and risk factors may help improve diagnosis, treatment, and prevention and 
benefit breeding operation economics.  
 
Objective 
To investigate incidence and phenotype of congenital orofacial clefts among purebred dogs, examine potential risk factors, and 
estimate financial impact on breeding programs. Methods: Dog breeders were solicited to participate in an anonymous survey 
through invitations sent to various kennel clubs. Breeders having whelped a litter in the past 12 months were eligible to 
participate. Litters affected by other congenital abnormalities were excluded from analysis. Breed, genetic clade, skull 
conformation, litter size, sex, and geographic area were analyzed for associations with clefts.  
 
Results 
Among 7,429 puppies born in the 12 preceding months, 226 orofacial clefts (3%) were reported. Breeds in the mastiff-terrier 
genetic cluster were at increased odds of orofacial clefts of any type (OR, 2.72; 95% CI, 1.89 to 3.90; P < 0.001), cleft lips (OR, 
1.77; 95% CI, 1.01 to 3.11; P = 0.0455), cleft palates (OR, 2.62; 95% CI, 1.70 to 4.03; P < 0.001), and both (OR, 4.75; 95% CI, 
1.81 to 12.46; P < 0.001). Breeds in the ancient breed cluster were at increased odds of orofacial clefts of any type (OR, 2.91; 
95% CI, 1.53 to 5.53; P < 0.001) and cleft palates (OR, 4.43; 95% CI, 2.13 to 9.22; P < 0.001). Brachycephalic breeds were at 
increased odds of orofacial clefts of any type (OR, 4.75; 95% CI, 3.57 to 6.31; P < 0.001), cleft lips (OR, 9.12; 95% CI, 4.88 to 
17.03; P < 0.001), cleft palates (OR, 2.60; 95% CI, 1.81 to 3.73; P < 0.001), and both (OR, 20.47; 95% CI, 7.18 to 58.31; P < 
0.001). 
 
Conclusions 
Results support our clinical impressions that certain breeds, especially brachycephalic breeds, are overrepresented among cases 
of orofacial clefts. 
 
 
 
 
 
 
 
 
 
 17 
 
 Jessica Wallis, BVSc (Hons) 
jlw399@cornell.edu  
Institution and Location 
The University of Melbourne, Melbourne, Australia 
VCA Southpaws Vet. Spec, & Emer. Center, Fairfax, VA 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Emergency and Critical Care, 3rd Year 
Degree 
BVSc 
Internship 
Residency 
Year 
2013 
2015 
2016-Present 
 
Abstract Title: 
An Analysis of Medical Error Type and Severity in Veterinary Hospitals Through the Use of an Incident Reporting System 
 
Authors Names: 
Jessica L. Wallis,1 John W. Ludders1, Daniel J. Fletcher,1 Adrienne Bentley2 
 
1 Clinical Sciences, Cornell University, Ithaca, New York  
2 Cornell University Veterinary Specialists, Stamford, Connecticut 
 
Project Mentor(s): 
Daniel J. Fletcher, PhD, DVM, DACVECC, Department of Clinical Sciences 
 
Abstract: 
Introduction 
Medical errors are commonly regarded as a leading cause of mortality in human medicine. In contrast, errors in veterinary 
medicine are rarely discussed, and there is little knowledge regarding their nature and frequency. 
 
Objective 
To evaluate the type and severity of medical errors reported in three veterinary hospitals. 
 
Methods 
The voluntary online incident reporting systems of a small animal teaching hospital, large animal teaching hospital, and small 
animal private practice were reviewed. Reports were included if they were entered between February 2015 and March 2018, 
and involved an incident pertaining to patient safety. The reporting systems included classification of errors into the following 
categories: drug, iatrogenic, system, communication, lab, oversight, staff, or equipment errors. In addition, all incidents were 
classified as resulting in either a near miss, harmless hit, adverse incident or unsafe condition. Adverse incidents were further 
evaluated for error severity retrospectively. 
 
Results 
A total of 560 incident reports were included for analysis. Drug errors were the most frequently reported in all three hospitals, 
followed by failures of communication. Errors most commonly reached patients without causing harm (45%); however, 15% 
of all incidents resulted in patient harm. Eight percent of these patients suffered permanent harm or death. 
 
Discussion 
This study demonstrates that medical errors have a substantial impact on veterinary patients. Establishing that drug and 
communication errors are most frequent in a variety of hospitals is the first step towards interventions to improve patient 
safety and outcomes in veterinary medicine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 18 
 
 Christophe Bourguignon, DVM 
cb844@cornell.edu  
Institution and Location 
VetAgro Sup, Lyon, France 
National School of Veterinary Medicine of Alfort, France 
IHU LIRYC (arrhythmia and interventional research center) 
North Carolina State University, Raleigh, North Caroline 
Cornell University, Ithaca, New York 
 
Current Position 
Resident, Cardiology, 2nd Year 
Degree 
DVM 
Rot. Internship 
Fellowship 
ECC Internship 
Residency 
Year 
2014 
2014-2015 
2015-2016 
2016-2017 
2017-Present 
 
Abstract Title: 
QT Restitution in Boxers with ARVC: Relationship to Arrhythmia Vulnerability and Treatment Response 
 
Authors Names: 
Christophe Bourguignon1, N. Sydney Moise1, Romain Pariaut1 
 
1 Department of Clinical Sciences, Cornell University, Ithaca, New York  
 
Project Mentor(s): 
N. Sydney Moise, DVM, MS, DACVIM (SAIM, Cardiology), Department of Clinical Sciences (mentor) 
Romain Pariaut, DVM, DACVIM, DECVIM (Cardiology), Department of Clinical Sciences (co-mentor) 
 
Abstract: 
Introduction 
Morbidity and mortality are high in Boxers diagnosed with Arrhythmogenic Right Ventricular Cardiomyopathy 
(ARVC), which affects approximately 60% of all dogs in this breed. Ventricular arrhythmias (VA) are commonly 
present and have a high potential for degeneration to fatal ventricular fibrillation. Currently, sotalol, a potassium 
channel blocker and β-adrenergic blocker is the first line antiarrhythmic used to decrease the frequency and 
severity of VA. This response may be related to its effect on cardiac repolarization and heart rate, reflected by 
the QT and TQ interval duration on the electrocardiogram. 
 
Objective and Methods 
To understand the mechanism behind VA in Boxers with ARVC and the reason for a between-dog variability of 
response to sotalol. In this study, Boxers with more than 10,000 VA per 24 hours on Holter recordings and 
treated with sotalol are selected. An 85% reduction in VA number identifies response to treatment. ECG 
restitution techniques to evaluate the ratio between the working phase (QT interval) and the resting phase (TQ 
interval) of the ventricles are applied to digital electrocardiographic recordings. Furthermore, the association 
between restitution parameters and VA are studied. 
 
Hypothesis 
We hypothesize that ECG restitution parameters distinguish Boxers that respond to sotalol therapy from those 
that experience a smaller reduction in VA. Preliminary results indicate an impact of sotalol therapy on 
restitution parameters. It remains to be determined whether this effect is independent from heart rate changes 
after treatment, and if it is associated with VA reduction. 
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Abstract: 
Background / Rationale for the Study 
Buprenorphine is the first-line opioid used for analgesia in rabbits. Buprenorphine significantly reduces gastrointestinal (GI) 
motility, reduces fecal output, and delays GI transit time in rabbits. These deleterious effects may discourage the use of 
buprenorphine or other opioids in rabbits. Cisapride is a gastroprokinetic agent that promotes gastric emptying in a variety of 
species. Cisapride has been used anecdotally for GI stasis in rabbits, but its effectiveness at ameliorating opioid-induced GI 
stasis in this species has not been investigated. We hypothesize that cisapride decreases GI transit time if administered alone. 
We further hypothesize that the addition of cisapride when co-administered with buprenorphine will significantly reduce 
opioid-induced GI stasis in New Zealand White rabbits. In this study, we will first determine the most efficacious method of 
measuring GI transit time in rabbits. We will then administer 4 different treatments to rabbits in random order: 
buprenorphine, cisapride, buprenorphine+cisapride, and normal saline twice a day for 2 days. Fecal production will be 
measured every 6 hours, and water/food consumption, and body weight will be measured daily for 5 days after each treatment. 
We expect that cisapride will reduce GI transit time, and that when combined with buprenorphine, will reduce GI transit time 
compared to buprenorphine alone. This study will impact rabbit welfare by showing that some of the GI side effects of 
buprenorphine can be minimized, leading to less hesitation when using opioids for analgesia in this species. 
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Abstract: 
Proximal sesamoid bone (PSB) fractures are the most common cause of catastrophic injuries on Thoroughbred racetracks in 
North America and Hong Kong, yet PSB fracture etiology is poorly understood. It is unclear whether fractures occur as acute, 
traumatic monotonic fractures or are the result of chronic, cyclical bone stress with inadequate secondary bone remodeling. 
The goal of this research is to determine whether there are differences in the amount of microdamage accumulation in PSBs in 
horses sustaining fracture as compared to sex-age-matched controls (SAMC), to assess whether intact PSBs from the 
contralateral limb of fracture horses (FXCL) have reduced fracture toughness, and to investigate the amount of microfracture 
that occurs during fracture testing. Our first hypothesis is that PSBs undergoing catastrophic failure will have evidence of pre-
existing microdamage. To test this hypothesis, microdamage will be assessed in SAMC and fractured PSBs using lead uranyl 
acetate (UA) staining and micro-CT for volumetric assessment and basic fuchsin staining for histologic assessment of 
microarchitecture. Second, fracture toughness is thought to be higher in more porous bone as it facilitates dissipation of 
fracture energy in the form of microfracture. Therefore, we postulate that PSBs from SAMC will have increased microfracture 
following three-point-bending fracture toughness testing, hence increased fracture toughness compared to FXCL. Following 
dissection, imaging, and morphometric measurements of PSBs, fracture toughness will be assessed using in vitro mechanical 
testing. Fracture toughness will be compared between FXCL and SAMC, and correlated with morphometric measurements, 
bone density, and microfracture volume as measured via micro-CT. 
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Abstract: 
Literature Review 
Cutaneous mast cell tumor (MCT) is one of the commonest malignant cutaneous tumors in dogs. Current treatment standards 
include wide-margin surgical excision of the primary tumor with regional lymph node excision and chemotherapy if nodal 
metastasis is present. Removal of the draining lymph node in combination with surgical excision of the primary tumor has 
been shown to extend survival times in the context of multiple malignant tumor types in both humans and animals. Draining 
node removal appears to confer both a therapeutic advantage by reducing the cancer burden, as well as a diagnostic advantage 
by improving the accuracy of staging of disease for the individual, with associated alteration in recommended therapy and 
monitoring. The success of this approach relies on successful identification and removal of the correct draining lymph node(s), 
known as the sentinel lymph node(s) (SLN). 
 
Rational for Study 
The SNL is not necessarily the same as the regional node predicted by anatomic location of the tumor. Multiple techniques 
have been developed in human oncology to determine the sentinel node(s) and some of these techniques may be applicable to 
animals. 
 
Scientific Design 
Observational cohort study using ICTL with 4 quadrant peri-tumoral iopamidol injection in client owned dogs (n=20) with 
MCT >1cm undergoing surgical excision of the MCT and identified SLN. 
 
Hypothesis and Expected Outcomes 
ICTL is a useful technique for identification of sentinel lymph nodes in dogs with MCT which will facilitate removal of the 
SLN, and influence operative decision making and post-operative recommendations. 
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Abstract: 
Background/Rationale 
Background/Rationale: SOX2 is a major transcriptional regulator of embryonic stem cell pluripotency, and self-renewability. 
Its expression in cancer stem cells from at least 25 different tumors in humans and rodent models has directly implicated it in 
tumorigenicity, metastasis, drug resistance, recurrence, and poor survival. Thus far in veterinary medicine, the SOX2 gene is 
overexpressed in metastatic canine mammary tumors, and isolation of primary canine osteosarcoma cell cultures proved that 
SOX2-positive cells exhibit distinctive sensitivity to drugs with potential to inhibit proliferation, metastasis, and self-renewal. 
Recognizing alterations of SOX2 expression between normal and neoplastic tissues is an essential step for better 
understanding tumor biology and the roots of canine cancer. 
 
Objective/Hypothesis 
To investigate the expression of SOX2 in canine malignancies, hypothesizing that variations in SOX2 expression directly relate 
to tumorigenicity and tumor progression in different types of cancer. 
 
Scientific Design 
Immunohistochemistry for SOX2 will be performed on archived formalin-fixed paraffin-embedded canine biopsy tissues 
diagnosed with various epithelial, mesenchymal, neuroectodermal and hematopoietic tumors. Results will be compared with 
SOX2 immunoreactivity in normal canine tissues (via tissue microarray), and summarized using standard descriptive statistics. 
 
Expected Outcomes 
This study will provide new insights into the molecular pathways of canine malignancies, potentially representing a valuable 
comparative model for human cancer, and may offer novel clinical applications for SOX2 as a prognostic indicator. Screening 
methods based on cellular plasticity and pluripotency biomarkers will help provide avenues for the rational design of 
therapeutic strategies that target vulnerable signals upstream or downstream of SOX2 in different cancer types. 
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